Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 9/6/2024 | $72.00 | Buy → Hold | TD Cowen | |
| 7/18/2024 | Peer Perform | Wolfe Research | ||
| 1/10/2024 | $63.00 | Overweight | KeyBanc Capital Markets | |
| 12/13/2023 | Outperform → Neutral | Exane BNP Paribas | ||
| 6/22/2023 | Underweight → Equal-Weight | Morgan Stanley | ||
| 2/27/2023 | $74.00 → $85.00 | Neutral → Buy | Goldman | |
| 1/12/2023 | Outperform → Peer Perform | Wolfe Research | ||
| 12/2/2022 | $65.00 | Buy | BofA Securities |
TD Cowen downgraded KBR from Buy to Hold and set a new price target of $72.00
Wolfe Research resumed coverage of Shell plc with a rating of Peer Perform
KeyBanc Capital Markets resumed coverage of KBR with a rating of Overweight and set a new price target of $63.00
KBR (NYSE:KBR) has outperformed the market over the past 10 years by 1.1% on an annualized basis producing an average annual return of 11.79%. Currently, KBR has a market capitalization of $9.01 billion. Buying $100 In KBR: If an investor had bought $100 of KBR stock 10 years ago, it would be worth $299.55 today based on a price of $67.07 for KBR at the time of writing. KBR's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed by an editor.
Updated Fiscal 2024 Guidance The table below summarizes updated FY24 guidance and represents our views as of July 24, 2024. Updated guidance does not reflect the anticipated acquisition of LinQuest. Updated Fiscal 2024 Guidance Prior Fiscal 2024 Guidance Revenue $7.4B - $7.7B $7.4B - $7.7B Adjusted EBITDA $825M - $850M $810M - $850M Diluted EPS* $2.94 - $3.09 $2.88 - $3.08 Adjusted EPS* $3.15 - $3.30 $3.10 - $3.30 Operating cash flows $460M - $480M $45
KBR (NYSE:KBR) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.79 by 5.06 percent. This is a 12.16 percent increase over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $1.855 billion which missed the analyst consensus estimate of $1.876 billion by 1.11 percent. This is a 5.82 percent increase over sales of $1.753 billion the same period last year.
SC 13G/A - KBR, INC. (0001357615) (Subject)
SC 13G/A - KBR, INC. (0001357615) (Subject)
SC 13G/A - KBR, INC. (0001357615) (Subject)
6-K - Shell plc (0001306965) (Filer)
25-NSE - Shell plc (0001306965) (Subject)
6-K - Shell plc (0001306965) (Filer)
4 - KBR, INC. (0001357615) (Issuer)
4 - KBR, INC. (0001357615) (Issuer)
4 - KBR, INC. (0001357615) (Issuer)
4 - KBR, INC. (0001357615) (Issuer)
Shell plc Shell welcomes Dutch Court of Appeal ruling November 12, 2024 Today, the Court of Appeal of The Hague overturned the District Court of The Hague's 2021 ruling in the case brought against Shell plc by Milieudefensie, other NGOs and a group of private individuals. "We are pleased with the court's decision, which we believe is the right one for the global energy transition, the Netherlands and our company," said Shell plc Chief Executive Officer Wael Sawan. "Our target to become a net-zero emissions energy business by 2050 remains at the heart of Shell's strategy and is transforming our business. This includes continuing our work to halve emissions from our operations by 20301.
SHELL PLC 2025 INTERIM DIVIDEND TIMETABLE London, October 31, 2024 The Board of Shell plc today announced the intended timetable for the 2025 quarterly interim dividends. 2025 Interim Dividend Timetable Event 4th Quarter 2024 1st Quarter 2025 2nd Quarter 2025 3rd Quarter 2025 Announcement date January 30, 2025 May 2, 2025 July 31, 2025 October 30, 2025 Ex- Dividend Date for ADSs February 14, 2025 May 16, 2025 August 15, 2025 November 14, 2025 Ex- Dividend Date for ordinary shares February 13, 2025 May 15, 2025 August 14, 2025 November 13, 2025 Record date February 14, 2025 May 16, 2025 August
Shell plc Shell announces commencement of a share buyback programme October 31, 2024 Shell plc (the ‘Company') today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme'). The purpose of the programme is to reduce the issued share capital of the Company. All shares repurchased as part of the programme will be cancelled. It is intended that, subject to market conditions, the programme will be completed prior to the Company's Q4 2024 results announcement, scheduled for January 30, 2025. The Company has entered into an arrangement with a single broker consisting of two irrevocable, non-discret
HOUSTON, Aug. 12, 2024 /PRNewswire/ -- KBR (NYSE:KBR) announced today the appointment of Nchacha E. Etta to its Board of Directors effective August 12, 2024. Nchacha E. Etta is executive vice president and chief financial officer of Omnicell, Inc., a multinational healthcare technology company. His breadth of finance and accounting experience stems from leading and working in global finance organizations across the healthcare and consumer products industries for more than 20 years. Prior to joining Omnicell, Mr. Etta served as senior vice president and chief financial officer
NOTICE OF 2024 ANNUAL GENERAL MEETING Shell plc's 2024 Annual General Meeting ("AGM") scheduled to be a hybrid meeting, facilitating both physical and virtual attendance. Board requests shareholder support for Company's energy transition update, as disclosed in Shell plc's Annual Report and the Energy Transition Strategy 2024. Shareholders encouraged to vote in advance of the AGM, but voting enabled during the meeting for those formally in attendance. Today, Shell plc (the "Company") posted its Notice of 2024 Annual General Meeting (the "Notice"), which can be viewed and downloaded from shell.com/agm. The AGM is scheduled to be held at the InterContinental London – The O2, 1 Waterview Dri
HOUSTON, Dec. 18, 2023 /PRNewswire/ -- KBR (NYSE:KBR) is pleased to join forces with The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) on an important contract to support neuroscience research for service members. This new award will specifically focus on those affected by traumatic brain injuries. Research will be done in collaboration with the Uniformed Services University (the nation's only federal health sciences university), and the University of California San Francisco (UCSF). Under the terms of the Service Personnel Advancing Research in Ch
Transaction in Own Shares 22 November, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 22 November 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchaseNumber of Shares purchasedHighest price paidLowest price paid Volume weighted average price paid per shareVenueCurrency22/11/20241,023,000 £26.1800£25.9300£26.0541LSEGBP22/11/2024- £0.0000£0.0000£0.0000Chi-X (CXE)GBP22/11/2024- £0.0000£0.0000£0.0000BATS (BXE)GBP22/11/2024650,000 €31.8050€31.4600€31.6149XAMSEUR22/11/2024- €0.0000€0.0000€0.0000CBOE DXEEUR22/11/2024- €0.0000€0.0000€0.0000TQEXEUR These share p
HOUSTON, Nov. 22, 2024 /PRNewswire/ -- KBR (NYSE:KBR) announced today that it has signed an agreement with AMUFERT for the development of a new ammonia plant in Soyo, Angola. Under the terms of the contract, KBR will provide a technology license, proprietary engineering design, equipment and catalyst solutions for AMUFERT's 2,300 metric tons per day ammonia plant. Leveraging KBR's proprietary technologies and expertise in ammonia, the planned facility will assist Angola and its neighboring countries move towards greater food security and self-sufficiency. "We are thrilled to b
Transaction in Own Shares 20 November, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 20 November 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchaseNumber of Shares purchasedHighest price paidLowest price paid Volume weighted average price paid per shareVenueCurrency20/11/20241,135,000 £25.7500£25.4800£25.6041LSEGBP20/11/2024- £0.0000£0.0000£0.0000Chi-X (CXE)GBP20/11/2024- £0.0000£0.0000£0.0000BATS (BXE)GBP20/11/2024774,000 €31.2350€30.9600€31.0937XAMSEUR20/11/2024- €0.0000€0.0000€0.0000CBOE DXEEUR20/11/2024- €0.0000€0.0000€0.0000TQEXEUR These share p